Home
Resources
Diseases
COVID-19
Ebola
Hepatitis B
Human papillomavirus (HPV)
Malaria
Measles
Mpox
Pneumococcal disease
RSV (Respiratory syncytial virus)
Compendium
Hepatitis B birth dose vaccines
Hexavalent vaccines
HPV vaccines
Malaria vaccines
Measles containing vaccines
PCV vaccines
RSV vaccines
Typhoid Conjugate Vaccines
Training
Vaccine Portfolio Optimization and Prioritization (VPOP)
Evaluation
The Tool
The Tutorial
The Dashboard
SYSVAC
About
Registry
E-learning courses
News
Webinars
Network
Steering Committee
Vision and Mission
Map
Meetings
Partners
Join us
Home
Resources
Resources
Selected
Pneumococcal disease
Type of publications
Guidelines (1)
NITAG documentation (94)
Reports (2)
SAGE documentation (12)
Scientific publications (2)
Systematic reviews (SYSVAC) (199)
Regions
Africa (13)
Americas (55)
Eastern Mediterranean (1)
Europe (45)
South-East Asia (5)
Western Pacific (18)
Diseases
Pneumococcal disease (310)
Chikungunya (13)
Cholera (35)
COVID-19 (1599)
Cytomegalovirus (1)
Dengue (45)
Diphtheria (92)
Ebola (21)
Escherichia coli (ETEC) (2)
Haemophilus influenzae type B (72)
Hepatitis A (71)
Hepatitis B (175)
Hepatitis C (5)
Hepatitis E (5)
Herpes simplex (1)
Herpes zoster (81)
HIV / AIDS (10)
Human papillomavirus (HPV) (545)
Influenza (639)
Japanese encephalitis (35)
Lyme disease, Borreliosis (2)
Malaria (35)
Measles (148)
Meningococcal disease (157)
Moraxella catarrhalis (1)
Mpox (59)
Mumps (53)
Pertussis (122)
Poliomyelitis (98)
Q fever (1)
Rabies (33)
Rotavirus (122)
RSV (Respiratory syncytial virus) (71)
Rubella (72)
Salmonella (3)
Shigella (1)
Smallpox (16)
Streptococcus group B (6)
Tetanus (73)
Tick-borne encephalitis (14)
Tuberculosis (84)
Typhoid (33)
Varicella (79)
Yellow fever (45)
Zika (1)
Show more
Methodological quality (AMSTAR 2)
High (11)
Moderate (2)
Low (20)
Critically low (90)
Not applicable (76)
310 results found
2010
∙
ACIP
Licensure of a 13-Valent Pneumococcal Conjugate Vaccine (PCV13) and Recommendations for Use Among Children
2010
∙
Ministerio de Sanidad, Servicios Sociales e Igualdad
New Conjugate Pneumococcal Vaccines
2010
∙
ACIP
Prevention of Pneumococcal Disease Among Infants and Children --- Use of 13-Valent Pneumococcal Conjugate Vaccine and 23-Valent Pneumococcal Polysaccharide Vaccine
2010
∙
Centre for Health Protection
Recommendations on the Interchangeability between 7-valent Pneumococcal Conjugate Vaccine (PCV7) and 10-valent Pneumococcal Conjugate Vaccine (PCV10)
2010
∙
ACIP
Updated Recommendations for Prevention of Invasive Pneumococcal Disease Among Adults Using the 23-Valent Pneumococcal Polysaccharide Vaccine (PPSV23)
2010
∙
Health Council of the Netherlands
Vaccination of infants against pneumococcal infections (2) - 10 March 2010
2008
∙
Christine Navarro, James Kellner
NACI Statement on the recommended use of pneumococcal 23-valent polysaccharide vaccine in homeless persons and injection drug users - September 2008
2008
∙
ACIP
Use of 7-Valent Pneumococcal Conjugate Vaccine (PCV7) in Children Aged 24--59 Months Who Are Not Completely Vaccinated
2008
∙
YL Lau, Susan Chiu, PL Ho, YY Cheung, CB Chow, Teresa Choi
Use of Hepta-valent Pneumococcal Conjugate Vaccine in the Childhood Immunisation Programme - October 2008
2006
∙
Conseil Supérieur de la Santé (CSS)
Vaccination strategy for the Pneumococcal Conjugate Vaccine
Home
Resources
Diseases
Compendium
Training
Evaluation
SYSVAC
News
Webinars
Network
Sign in / Register
